Disturbance of the Warburg Effect by Dichloroacetate and Niclosamide Suppresses the Growth of Different Sub-types of Malignant Pleural Mesothelioma and

Overview

Journal Front Pharmacol

Date 2022 Oct 28

PMID 36304150

Authors

Sze-Kwan Lam

Sheng Yan

Joyce Sze-Man Lam

Yuqian Feng

Mahjabin Khan

Caoyang Chen

Frankie Chi-Fat Ko

James Chung-Man Ho

Affiliations

Soon will be listed here.

Abstract

Inhalation of asbestos fibers is the most common cause of malignant pleural mesothelioma (MPM). In 2004, the United States Food and Drug Administration approved a combination of cisplatin with pemetrexed to treat unresectable MPM. Nonetheless novel treatment is urgently needed. The objective of this study is to report the combination effect of dichloroacetate (DCA) or niclosamide (Nic) Nic in MPM. The effect of a combination of DCA and Nic was studied using a panel of MPM cell lines (H28, MSTO-211H, H226, H2052, and H2452). Cell viability was monitored by MTT assay. Glycolysis, oxidative phosphorylation, glucose, glycogen, pyruvate, lactate, citrate, succinate and ATP levels were determined by corresponding ELISA. Apoptosis, mitochondrial transmembrane potential, cell cycle analysis, hydrogen peroxide and superoxide were investigated by flow cytometry. Cell migration and colony formation were investigated by transwell migration and colony formation assays respectively. The effect was confirmed using 211H and H226 nude mice xenograft models. Cell viability was reduced. Disturbance of glycolysis and/or oxidative phosphorylation resulted in downregulation of glycogen, citrate and succinate. DCA and/or Nic increased apoptosis, mitochondrial transmembrane depolarization, G2/M arrest and reactive oxygen species. Moreover, DCA and/or Nic suppressed cell migration and colony formation. Furthermore, a better initial tumor suppressive effect was induced by the DCA/Nic combination compared with either drug alone in both 211H and H226 xenograft models. In H226 xenografts, DCA/Nic increased median survival of mice compared with single treatment. Single drug and/or a combination disturbed the Warburg effect and activated apoptosis, and inhibition of migration and proliferation . In conclusion, dichloroacetate and/or niclosamide showed a tumor suppressive effect in MPM and partially mediated by disturbance of glycolysis/oxidative phosphorylation, apoptosis, ROS production, G2/M arrest, and suppression of migration and proliferation.

Citing Articles

Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts.

Koltai T, Fliegel L Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931411 PMC: 11206832. DOI: 10.3390/ph17060744.

Niclosamide Attenuates Inflammation-Associated Profibrotic Responses in Human Subepithelial Lung Myofibroblasts.

Spathakis M, Tarapatzi G, Filidou E, Kandilogiannakis L, Karatzas E, Steiropoulos P Biomedicines. 2023; 11(7).

PMID: 37509671 PMC: 10377180. DOI: 10.3390/biomedicines11072032.

References

Lam S, Li Y, Xu S, Leung L, U K, Zheng Y . Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts. Respir Res. 2017; 18(1):80. PMC: 5414232. DOI: 10.1186/s12931-017-0564-3. View

Vogelzang N, Rusthoven J, Symanowski J, Denham C, Kaukel E, Ruffie P . Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003; 21(14):2636-44. DOI: 10.1200/JCO.2003.11.136. View

Tian D, Bennett S, Coupland L, Forwood K, Lwin Y, Pooryousef N . genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial. Pharmacol Res Perspect. 2019; 7(6):e00526. PMC: 6783648. DOI: 10.1002/prp2.526. View

Icard P, Philippe I, Zhang X, Xiao-Dong Z, Lemoisson E, Edwige L . Experimental results using 3-bromopyruvate in mesothelioma: in vitro and in vivo studies. J Bioenerg Biomembr. 2012; 44(1):81-90. DOI: 10.1007/s10863-012-9415-6. View

Florio R, De Lellis L, Veschi S, Verginelli F, di Giacomo V, Gallorini M . Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells. Sci Rep. 2018; 8(1):13610. PMC: 6134030. DOI: 10.1038/s41598-018-31797-5. View

Yeh L, Lin C, Lu K, Hsieh Y, Yeh C, Yang S . Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway. Int J Mol Sci. 2022; 23(1). PMC: 8745393. DOI: 10.3390/ijms23010484. View

Ortega-Guerrero M, Carrasco-Nunez G, Barragan-Campos H, Ortega M . High incidence of lung cancer and malignant mesothelioma linked to erionite fibre exposure in a rural community in Central Mexico. Occup Environ Med. 2014; 72(3):216-8. DOI: 10.1136/oemed-2013-101957. View

Alasadi A, Chen M, Swapna G, Tao H, Guo J, Collantes J . Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer. Cell Death Dis. 2018; 9(2):215. PMC: 5833462. DOI: 10.1038/s41419-017-0092-6. View

Han Z, Li Q, Wang Y, Wang L, Li X, Ge N . Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis. Front Pharmacol. 2019; 9:1544. PMC: 6333743. DOI: 10.3389/fphar.2018.01544. View

10.

Duan Y, Zhao X, Ren W, Wang X, Yu K, Li D . Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation. Onco Targets Ther. 2013; 6:189-98. PMC: 3601023. DOI: 10.2147/OTT.S40992. View

11.

Klose K, Packeiser E, Muller P, Granados-Soler J, Schille J, Goericke-Pesch S . Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line. PLoS One. 2021; 16(9):e0257403. PMC: 8476037. DOI: 10.1371/journal.pone.0257403. View

12.

El Sayed S, Baghdadi H, Ahmed N, Almaramhy H, Mahmoud A, El-Sawy S . Dichloroacetate is an antimetabolite that antagonizes acetate and deprives cancer cells from its benefits: A novel evidence-based medical hypothesis. Med Hypotheses. 2018; 122:206-209. DOI: 10.1016/j.mehy.2018.11.012. View

13.

Wieland A, Trageser D, Gogolok S, Reinartz R, Hofer H, Keller M . Anticancer effects of niclosamide in human glioblastoma. Clin Cancer Res. 2013; 19(15):4124-36. DOI: 10.1158/1078-0432.CCR-12-2895. View

14.

Sun L, Suo C, Li S, Zhang H, Gao P . Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect. Biochim Biophys Acta Rev Cancer. 2018; 1870(1):51-66. DOI: 10.1016/j.bbcan.2018.06.005. View

15.

Tong J, Xie G, He J, Li J, Pan F, Liang H . Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer. J Biomed Biotechnol. 2011; 2011:740564. PMC: 3043319. DOI: 10.1155/2011/740564. View

16.

Shen M, Young A, Autexier C . PCNA, a focus on replication stress and the alternative lengthening of telomeres pathway. DNA Repair (Amst). 2021; 100:103055. DOI: 10.1016/j.dnarep.2021.103055. View

17.

Zhang Y, Guo G, Ma B, Du R, Xiao H, Yang X . A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting. Anticancer Drugs. 2015; 26(7):698-705. DOI: 10.1097/CAD.0000000000000234. View

18.

Korsakova L, Krasko J, Stankevicius E . Metabolic-targeted Combination Therapy With Dichloroacetate and Metformin Suppresses Glioblastoma Cell Line Growth and . In Vivo. 2021; 35(1):341-348. PMC: 7880769. DOI: 10.21873/invivo.12265. View

19.

Shen H, Hau E, Joshi S, Dilda P, McDonald K . Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism. Mol Cancer Ther. 2015; 14(8):1794-804. DOI: 10.1158/1535-7163.MCT-15-0247. View

20.

Dogan Sigva Z, Balci Okcanoglu T, Biray Avci C, Yilmaz Susluer S, Kayabasi C, Turna B . Investigation of the synergistic effects of paclitaxel and herbal substances and endemic plant extracts on cell cycle and apoptosis signal pathways in prostate cancer cell lines. Gene. 2018; 687:261-271. DOI: 10.1016/j.gene.2018.11.049. View